Ipca Takes Full Ownership Of Bayshore
Strikes Deal To Acquire Remaining 20% Holding In US Generics Firm
Ipca has struck a deal to take full ownership of US firm Bayshore Pharmaceuticals by acquiring the remaining 20% stake that it did not already own.